PRESTIGE BIOLOGICS

Prestige Biologics offers a <4-Week BUDGET ESTIMATION PROGRAM>.
Regardless of the stage of your biopharmaceutical pipeline, through our estimation program, you can assess the required budget and production technology to predict and prepare for the future. Discover cost-effectiveness strategies with us as your CMO/CDMO partner. Within 4 weeks, you can confirm the budget you need for the future.

Prestige Biologics offers CMO/CDMO service with state-of-the-art facilities. EMA GMP certificated. antibody, recombinant.

Prestige Biologics operates state-of-the-art Drug Substance (DS) production facilities that effectively support both Upstream and Downstream processes. Our GMP facilities meet the most stringent global standards, contributing to the ecosystem of biopharmaceutical supply. Prestige Biologics offers customers production capabilities for monoclonal antibodies (mAb), bi-specific antibodies (bsAb), multi-antibodies, fusion antibodies, and recombinant proteins. We have accumulated extensive experience to ensure optimal production efficiency.

Drawing on our experience in process development and commercial production of several #biosimilars and #biologics pharmaceuticals in 2,000 L Single-Use Bioreactors, we are committed to sharing our expertise with our customers.

We hope to share our story of providing flexible and reliable Contract Manufacturing Organization (CMO) services for biopharmaceuticals at CPHI.
 

Prestige Biologics offers CMO/CDMO service with state-of-the-art facilities. EMA GMP certificated. antibody, recombinant.

Prestige Biologics offers CMO/CDMO service with state-of-the-art facilities. EMA GMP certificated. antibody, recombinant.

When do you start a conversation with a CDMO?

In the biopharmaceutical industry, the process of discovering, developing, and commercializing drugs brings significant pressure with extensive tasks. Specifically, considerations regarding the establishment of production technology and product manufacturing at each clinical stage may sometimes take a backseat due to daily demands. 
However, actively involving various Contract Manufacturing Organizations (CMOs) and seeking diverse opinions from the early stages can result in positive outcomes for future business development. Requirements in the production field may vary from those in the development stage, and the timing of involving CMOs can fluctuate with the pace of clinical research. Furthermore, unforeseen technological changes can cause delays in both technical and equipment preparations for production. Securing enough time for exchanging various...

PRESTIGE BIOLOGICS is a CDMO service provider in the production of biological drug substances (DS) derived from mammalian cells. We have four plants with a manufacturing capacity of 154,000L, certified by EU-GMP. We provide end-to-end service, drug products (DP) as well. Plants 1, 2, and 3 are equipped with single-use technology, while Plant 4 utilizes an advanced hybrid system.

For monoclonal antiobody drugs, bi-specific antibody and recombinant proteins, we provide the optimal experience.
#CDMO  #CMO #Biomanufacturing #Biosimilar #antibody #bispecific #recombinant 

As a part of One-Stop Solution that ease the management burden of pharmaceutical companies who applying for clinical trial, Prestige Biologics provide Secondary Packaging Service. From labeling to distribution, our CPO service cover your needs until your manufactured Investigational Products are delivered to clinical trial site. Experience our CPO service complied under GMP and GDP guidance.

PRESTIGE BIOLOGICS is a CDMO service provider in the production of biological drug substances (DS) derived from mammalian cells. We have four plants with a manufacturing capacity of 154,000L, certified by EU-GMP. We provide end-to-end service, drug products (DP) as well. Plants 1, 2, and 3 are equipped with single-use technology, while Plant 4 utilizes an advanced hybrid system.

For monoclonal antiobody drugs, bi-specific antibody and recombinant proteins, we provide the optimal experience.

#CDMO #CMO #Biomanufacturing

PRESTIGE BIOLOGICS is a CDMO service provider in the production of biological drug substances (DS) derived from mammalian cells. We have four plants with a manufacturing capacity of 154,000L, certified by EU-GMP. We provide end-to-end service, drug products (DP) as well. Plants 1, 2, and 3 are equipped with single-use technology, while Plant 4 utilizes an advanced hybrid system.

For monoclonal antiobody drugs, bi-specific antibody and recombinant proteins, we provide the optimal experience.

#CDMO #CMO #Biomanufacturing

PRESTIGE BIOLOGICS is a CDMO service provider in the production of biological drug substances (DS) derived from mammalian cells. We have four plants with a manufacturing capacity of 154,000L, certified by EU-GMP. We provide end-to-end service, drug products (DP) as well. Plants 1, 2, and 3 are equipped with single-use technology, while Plant 4 utilizes an advanced hybrid system.

For monoclonal antiobody drugs, bi-specific antibody and recombinant proteins, we provide the optimal experience.

#CDMO #CMO #Biomanufacturing

PRESTIGE BIOLOGICS is a CDMO service provider in the production of biological drug substances (DS) derived from mammalian cells. We have four plants with a manufacturing capacity of 154,000L, certified by EU-GMP. We provide end-to-end service, drug products (DP) as well. Plants 1, 2, and 3 are equipped with single-use technology, while Plant 4 utilizes an advanced hybrid system.For monoclonal antiobody drugs, bi-specific antibody and recombinant proteins, we provide the optimal experience.
#CDMO #CMO #Biomanufacturing #Bioprocessing

Clinical DP Filling System CMO
• Fully automated powerful control system that controls contamination by operator intervention
• Systems that support small-scale deployment and clinical-stage development
• Vial and Pre-Filled Syringe Production.

PRESTIGE BIOLOGICS is a CDMO service provider in the production of biological drug substances (DS) derived from mammalian cells. We have four plants with a manufacturing capacity of 154,000L, certified by EU-GMP. We provide end-to-end service, drug products (DP) as well. Plants 1, 2, and 3 are equipped with single-use technology, while Plant 4 utilizes an advanced hybrid system.

For monoclonal antiobody drugs, bi-specific antibody and recombinant proteins, we provide the optimal experience.

PRESTIGE BIOLOGICS is a CDMO service provider in the production of biological drug substances (DS) derived from mammalian cells. We have four plants with a manufacturing capacity of 154,000L, certified by EU-GMP. We provide end-to-end service, drug products (DP) as well. Plants 1, 2, and 3 are equipped with single-use technology, while Plant 4 utilizes an advanced hybrid system.

For monoclonal antiobody drugs, bi-specific antibody and recombinant proteins, we provide the optimal experience.